Beaten up share price offers an opportunity
06/06/25 -"After incorporating our 2027 projections with double-digit top-line growth due to the upcoming product launches, we have reduced our long-term sales and EBITDA growth estimates to 6% (7% previously). ..."
Pages
53
Language
English
Published on
06/06/25
You may also be interested by these reports :
12/06/25
Only a month ago we were lamenting the weakness of Pharmas, the second larget sector by market cap. The tide may have turned, strangely as part ...
11/06/25
Faes Farma made a good move to acquire the Italian ophthalmology firm SIFI, whose enterprise value is c.20% of Faes’ market cap. This deal would not ...
11/06/25
A sector review of ytd performance would show that the money was on Aerospace Defence and Financials. Pain was to be experienced with Consumer ...
10/06/25
A pest threatens the 2025 potato harvest with failure rates of up to 70%. We believe the driest spring on record has contributed to this. In the ...